Veterinary Medicines

Endogard Plus Flavour Tablets for dogs

Authorised
  • Febantel
  • Praziquantel
  • Pyrantel embonate
Download as PDF

Product identification

Medicine name:
Endogard Plus Flavour Tablets for dogs
Dehinel Plus Flavour, tabletid koertele
Active substance:
  • Febantel
  • Praziquantel
  • Pyrantel embonate
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Febantel
    150.00
    milligram(s)
    /
    1.00
    Tablet
  • Praziquantel
    50.00
    milligram(s)
    /
    1.00
    Tablet
  • Pyrantel embonate
    144.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AC55
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Estonia
Available in:
  • Estonia
Package description:
  • Nature of container: Print and perforated Alu-Alu blister: 2 tablets (1 blister with 2 tablets), in a box.
  • Nature of container: Print and perforated Alu-Alu blister: 4 tablets (2 blisters with 2 tablets), in a box.
  • Nature of container: Print and perforated Alu-Alu blister: 10 tablets (1 blister with 10 tablets), in a box.
  • Nature of container: Print and perforated Alu-Alu blister: 30 tablets (3 blisters with 10 tablets), in a box.
  • Nature of container: Print and perforated Alu-Alu blister: 50 tablets (5 blisters with 10 tablets), in a box.
  • Nature of container: Print and perforated Alu-Alu blister: 100 tablets (10 blisters with 10 tablets), in a box.
  • Nature of container: Print and perforated Alu-Alu blister: 300 tablets (30 blisters with 10 tablets), in a box.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
  • Krka-Farma d.o.o.
  • Virbac
  • KRKA tovarna zdravil d.d. Novo mesto
Responsible authority:
  • State Agency Of Medicines
Authorisation number:
  • 1641
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0539/001
Concerned member states:
  • Austria
  • Belgium
  • Czechia
  • Denmark
  • Estonia
  • Germany
  • Greece
  • Hungary
  • Italy
  • Latvia
  • Lithuania
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 13/10/2024
Download
Estonian (PDF)
Published on: 27/11/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."